Eiko Lifesciences Converts 305,000 Warrants to Equity Shares

Eiko Lifesciences Ltd announced the conversion of 305,000 warrants into equity shares, raising ₹1.25 crore. The conversion involved 130,000 warrants from promoter Bhavesh Dhirajlal Tanna and 175,000 from non-promoter V Square Pharmachem Private Limited. Each warrant was converted at an issue price of ₹55 per share, including a premium of ₹45. This conversion increases the company's issued, subscribed, and paid-up equity share capital to ₹14.65 crore, comprising 1,46,50,854 equity shares of ₹10 each. The newly allotted shares will rank pari-passu with existing equity shares.